Skip to main content

People With Alopecia Have Higher Risk for Inflammatory Arthritis

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

MONDAY, May 15, 2023 -- Alopecia areata (AA) is associated with a higher risk for inflammatory arthritis, according to a study published online April 28 in the Journal of the American Academy of Dermatology.

Colin M. Kincaid, from University of California at Irvine, and colleagues used medical records from 75 health care organizations (TriNetx) to determine if an association exists between AA and inflammatory arthritis. The analysis included 46,682 patients with AA and matched controls.

The researchers found that patients with AA had a significantly higher risk for developing psoriatic arthritis (odds ratio [OR], 2.344), rheumatoid arthritis (OR, 2.09), and ankylosing spondylitis (OR, 1.68) versus controls. Individuals with AA and concomitant inflammatory arthritis were mostly female, with the highest proportion having AA with rheumatoid arthritis (84 percent female). AA was also associated with the development of "other crystal arthropathies" (OR, 1.763) and "other inflammatory arthropathies" (OR, 1.631). Rates of gout were similar between the cohorts.

"In this large-scale cohort study, AA patients with inflammatory arthritis were older (average age, 54.4 years old), raising the question of whether we should screen patients with AA for arthritis and at what age," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted May 2023

Read this next

AAD: Continuous Improvements Seen Through 68 Weeks for Deuruxolitinib in Alopecia

TUESDAY, March 19, 2024 -- For adults with alopecia areata, continuous improvements are seen through 68 weeks with deuruxolitinib, according to a study presented at the annual...

AAD: Hair Regrowth Continues to Improve at 76 Weeks With Baricitinib for Severe Alopecia

MONDAY, March 18, 2024 -- Continuous treatment with baricitinib in patients with severe alopecia areata demonstrates improvement in hair regrowth outcomes through 76 weeks of...

Rheumatology Workforce Increased 20 Percent From 2009 to 2019

THURSDAY, March 14, 2024 -- The overall number of clinically active rheumatology providers grew more than 20 percent during the last decade, according to a study published online...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.